Brokers Set Expectations for VBI Vaccines Inc.’s Q2 2022 Earnings (NASDAQ:VBIV)

VBI Vaccines Inc. (NASDAQ:VBIV – Get Rating) – Investment analysts at Jefferies Financial Group upped their Q2 2022 earnings per share estimates for shares of VBI Vaccines in a research note issued to investors on Monday, May 9th. Jefferies Financial Group analyst R. Song now anticipates that the biopharmaceutical company will...

Read Full Story

If the content contained herein violates any of your rights, including those of copyright, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com

Jefferies Financial Group R. Song VBI VBI Vaccines VBI Vaccines Inc VBIV